News and Events
LakePharma Supplying Mount Sinai with SARS-CoV-2 Proteins for Serological Assays
Added on 2020-05-06LakePharma
today announces that the company will be supplying the Mount Sinai Health
System (Mount Sinai) recombinant SARS-CoV-2 spike proteins to the Mount Sinai
Laboratory as a component in its blood test for antibody response against SARS-CoV-2,
the virus that causes the COVID-19 pandemic.
Webinar recording now available - Part 2 :LakePharma Reagents & Assays for COVID-19 Antibody Response
Added on 2020-05-04Read More
Fresh Approaches to Antibody and Protein Discovery, Development, and Manufacturing
Added on 2020-04-27An interview by GEN with Dr. Hua Tu, CEO of LakePharma
Read MoreWebinar recording now available: LakePharma Reagents & Assays for COVID-19 Antibody Response
Added on 2020-04-09Thank you to those who attended our webinar on April 15. Webinar Recording is available now.
Read More